Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 18, 2024

BUY
$102.5 - $123.59 $632,937 - $763,168
6,175 New
6,175 $748,000
Q3 2023

Nov 13, 2023

BUY
$102.5 - $123.59 $632,937 - $763,168
6,175 New
6,175 $748,000
Q3 2022

Oct 18, 2024

BUY
$75.71 - $119.24 $435,786 - $686,345
5,756 New
5,756 $636,000
Q3 2022

Nov 10, 2022

BUY
$75.71 - $119.24 $435,786 - $686,345
5,756 New
5,756 $636,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.4B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.